肝炎病毒感染:感染的肝外表现和治疗选择
Krzysztof Simon1,2, Monika Pazgan-Simon2
1Department of Infectious Diseases and Hepatology, Faculty of Medicine, Wroclaw Medical University, Poland.
概括
型肝炎病毒 (HCV) 感染会影响多个器官,在30%-40%的患者中引起肝外症状 (EHM). 导致持续病毒学反应 (SVR) 的病毒消除是治疗肝病和EHMs的关键.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 肝炎C病毒 (HCV) 感染是一种全身性疾病,具有显著的肝外表现 (EHM).
- EHMs影响30%-40%的HCV感染个体,通常与免疫因素或直接的病毒影响有关.
- 肝炎通常与肝脏疾病一起发生,突出显示HCV的全身性质.
研究的目的:
- 要强调HCV感染的全身影响,包括其肝外表现.
- 强调病毒消除在控制HCV肝脏和肝外方面的关键作用.
- 为了将持续的病毒学反应 (SVR) 与EHM症状的缓解相关联.
主要方法:
- 审查有关HCV系统性影响和EHM的现有文献.
- 对EMM的流行率和影响的观察数据的分析.
- 病毒清除,SVR和EHM结果之间的相关性分析.
主要成果:
- 感染HCV超出了肝脏的范围,通过EHMs影响了各种器官.
- 通过自发清除或治疗实现的病毒消除对于患者的预后至关重要.
- 持续的病毒学反应 (SVR) 经常与临床EHM症状的缓解有关.
结论:
- 型肝炎是一种全身性疾病,需要全面的治疗方法,包括肝脏和肝外表现.
- 实现SVR是改善HCV和EHM患者治疗结果的主要治疗目标.
- 有效管理HCV感染可以导致显著改善或缓解EHM症状.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Gastritis III: Clinical Manifestations and Management
1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
Esophageal Varices-II: Clinical Features and Management
374
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
374
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
214
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
214
Acute Pancreatitis II: Clinical Manifestations and Management
756
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
756


